Literature DB >> 26304820

One of the Mechanisms to Increase HSV-1 Uptake in HSV-1-Infected, Activated T Lymphocytes Is the Formation of Filopodia.

Parvapan Bhattarakosol1, Pornnapa Donchai.   

Abstract

OBJECTIVES: To explore the host transcription factor E2F-1 and/or any mechanisms that may support viral entry and its effect on the HSV-1 production in anti-CD3-activated Jurkat cells.
METHODS: The expressions of ICP4, HVEM and E2F-1 were studied using reverse transcription-PCR and Western blot. HSV-1 production was determined by plaque titration assay and HSV-1 DNA load was quantified by real-time PCR. The viral uptake was observed by electron microscopy.
RESULTS: In anti-CD3-activated Jurkat cells, there was a significant increase in the HSV-1 production. The expression of ICP4 mRNA after HSV-1 infection occurred 2 h prior to the synthesis of the ICP4 protein, which was significantly higher in activated than nonactivated T cells. There were no significant differences in the expressions of E2F-1 mRNA. The HVEM expression was positively correlated with the HSV-1 DNA in the activated T cells. From the electron micrograph, the formations of filopodia were observed only in HSV-1-infected, activated cells.
CONCLUSIONS: High expressions of viral receptor protein and filopodia formations are the key factors that enhance the HSV-1 entry into activated T lymphocytes, resulting in an increased production of the virus.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26304820     DOI: 10.1159/000437264

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Actin Polymerization Is Required for Filopodia Formation Supporting HSV-1 Entry into Activated T Cells.

Authors:  Thanayod Sasivimolrattana; Pokrath Hansasuta; Supang Maneesri Le Grand; Parvapan Bhattarakosol
Journal:  Curr Microbiol       Date:  2021-12-14       Impact factor: 2.188

2.  Distinct migratory pattern of naive and effector T cells through the blood-CSF barrier following Echovirus 30 infection.

Authors:  Marie Wiatr; Carolin Stump-Guthier; Daniela Latorre; Stefanie Uhlig; Christel Weiss; Jorma Ilonen; Britta Engelhardt; Hiroshi Ishikawa; Christian Schwerk; Horst Schroten; Tobias Tenenbaum; Henriette Rudolph
Journal:  J Neuroinflammation       Date:  2019-11-21       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.